p38MAPK inhibitor and uses thereof
US6602896B1 · kind B1 · utility
0Cited by
0References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 31, 2000 |
| Grant date | Aug 5, 2003 |
| Priority date | — |
| Expiry date | Mar 31, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/4439
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention demonstrates that p38MAPK inhibitor induces low density lipoprotein receptor expression 6-8 fold, and further provides the application of such inhibitor in the treatment of hypercholesterolemia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.